RT Book, Section
A1 Gmelch, Ben
A2 Johnson, Ken B.
SR Print(0)
ID 1103964985
T1 Anesthetic Considerations During Cardiopulmonary Bypass
T2 Clinical Pharmacology for Anesthesiology
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 9780071736169
LK accessanesthesiology.mhmedical.com/content.aspx?aid=1103964985
RD 2024/04/24
AB Cardiothoracic  surgery  entails  unique,  often  extreme,  conditions  in  comparison  to  noncardiac  surgery.  Profound  hemodynamic  and  physiologic  perturbations  associated  with  hypothermic  cardiopulmonary  bypass  (CPB)  and  circulatory  arrest  lead  to  unique  dosing  considerations  for  anesthetic  drugs,  anticoagulants,  vasoactives,  inotropes,  and  antifibrinolytics.  This  chapter  will  review  the  pharmacologic  considerations  of  cardiac  anesthesia  chronologically  in  stages,  from  premedication  and  induction  to  pre-CPB  maintenance,  initiation  of  CPB,  separation  from  CPB,  and  the  post-CPB  period.  A  special  discussion  will  review  the  unique  pharmacologic  approach  to  anticipated  deep  hypothermic  circulatory  arrest  (DHCA).